BridgePort Financial Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1M Sell
128,811
-2,213
-2% -$57.9K 0.79% 33
2026
Q1
$3.68M Sell
131,024
-17
-0% -$453 1.04% 24
2025
Q4
$3.26M Sell
131,041
-278
-0.2% -$7.01K 0.88% 30
2025
Q3
$3.35M Buy
131,319
+116,927
+812% +$2.89M 0.9% 29
2025
Q2
$349K Buy
14,392
+1,680
+13% +$39.2K 0.12% 139
2025
Q1
$322K Buy
12,712
+32
+0.3% +$837 0.15% 121
2024
Q4
$331K Buy
+12,680
New +$344K 0.15% 119

Other funds holding PFE

BridgePort Financial Solutions's PFE Position: Q2 2026 in Review

BridgePort Financial Solutions reduced its Pfizer (PFE) stake by 1.7% in Q2 2026, selling an estimated $57.9K and leaving 128,811 shares worth $3.1M. The position accounts for 0.79% of the portfolio, ranked #33.

BridgePort Financial Solutions first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.68M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • BridgePort Financial Solutions held 128,811 shares of Pfizer worth $3.1M as of Q2 2026.
  • BridgePort Financial Solutions sold 2,213 Pfizer shares in Q2 2026, an estimated $57.9K.
  • Pfizer made up 0.79% of BridgePort Financial Solutions's portfolio in Q2 2026, its #33 holding.
  • BridgePort Financial Solutions first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • BridgePort Financial Solutions's Pfizer position peaked at $3.68M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on BridgePort Financial Solutions's 13F filing for Q2 2026, filed 24 Jul 2026.